AI Assistant
Blog
Pricing
Log In
Sign Up
Preclinical Potency and Safety Studies of an AAV2-Mediated Gene Therapy Vector for the Treatment of
MERTK
Associated Retinitis Pigmentosa
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.